University Of Texas/Texas Am Investment Management Co

Insider Reports History

Entity
Company
Location
210 W. 7 Th Street, Suite 1700, Austin, TX
Signature
/s/ Joan Moeller, Chief Operating Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by University Of Texas/Texas Am Investment Management Co:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aileron Therapeutics, Inc. 10%+ Owner Common Stock 1.75M $5.68M $3.25 Jun 17, 2024 Direct
Silver Point Specialty Lending Fund 10%+ Owner Common Stock 5M Jun 2, 2023 Direct

Insider Reports Filed by University Of Texas/Texas Am Investment Management Co

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALRN Aileron Therapeutics, Inc. Jun 14, 2024 2 -$21.6K 4 Jun 17, 2024 10%+ Owner
ALRN Aileron Therapeutics, Inc. Jun 10, 2024 5 -$80.7K 4 Jun 12, 2024 10%+ Owner
ALRN Aileron Therapeutics, Inc. Jun 5, 2024 5 -$40.5K 4 Jun 7, 2024 10%+ Owner
ALRN Aileron Therapeutics, Inc. May 1, 2024 16 -$85.5K 4/A May 14, 2024 10%+ Owner
ALRN Aileron Therapeutics, Inc. May 1, 2024 24 -$139K 4 May 1, 2024 10%+ Owner
ALRN Aileron Therapeutics, Inc. Feb 28, 2024 0 $0 3 Apr 30, 2024 10%+ Owner
N/A Silver Point Specialty Lending Fund Jun 2, 2023 0 $0 3 Jun 2, 2023 10%+ Owner